Filing Details
- Accession Number:
- 0001209191-19-014057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-27 16:22:33
- Reporting Period:
- 2019-02-25
- Accepted Time:
- 2019-02-27 16:22:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1662394 | Wayne Keith Ward | 2801 Gateway Drive Suite 150 Irving TX 75063 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2019-02-25 | 15,183 | $0.00 | 23,803 | No | 4 | C | Direct | |
| Class A Common Stock | Disposition | 2019-02-25 | 15,183 | $91.00 | 8,620 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2019-02-26 | 25,184 | $0.00 | 33,804 | No | 4 | C | Direct | |
| Class A Common Stock | Disposition | 2019-02-26 | 16,817 | $91.00 | 16,987 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2019-02-26 | 8,367 | $91.62 | 8,620 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | S | Direct | |
| No | 4 | C | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class B Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-25 | 15,183 | $0.00 | 15,183 | $11.00 |
| Class A Common Stock | Class B common stock | Acquisiton | 2019-02-25 | 15,183 | $11.00 | 15,183 | $0.00 |
| Class A Common Stock | Class B common stock | Disposition | 2019-02-25 | 15,183 | $0.00 | 15,183 | $0.00 |
| Class B Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-26 | 16,817 | $0.00 | 16,817 | $11.00 |
| Class B Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-02-26 | 8,367 | $0.00 | 8,367 | $11.62 |
| Class A Common Stock | Class B common stock | Acquisiton | 2019-02-26 | 16,817 | $11.00 | 16,817 | $0.00 |
| Class A Common Stock | Class B common stock | Acquisiton | 2019-02-26 | 8,367 | $11.62 | 8,367 | $0.00 |
| Class A Common Stock | Class B common stock | Disposition | 2019-02-26 | 25,184 | $0.00 | 25,184 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 92,967 | 2026-05-25 | No | 4 | M | Direct | |
| 15,183 | No | 4 | M | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 76,150 | 2026-05-25 | No | 4 | M | Direct | |
| 0 | 2023-06-15 | No | 4 | M | Direct | |
| 16,817 | No | 4 | M | Direct | ||
| 25,184 | No | 4 | M | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018.
- The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- The options, representing a right to purchase a total of 108,150 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016.
- The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013.
Billionaire Hedge Funds
